Responses to Psychotropic Drugs in the Normal Elderly

  • Carl Salzman
  • Richard I. Shader
Part of the Advances in Behavioral Biology book series (ABBI, volume 6)


Advancing age is often accompanied by disorders of mood and mental function. Common examples include depression that accompanies losses, anxiety over health and the future, agitation resulting from impaired perceptual processes, and impaired cognitive abilities stemming from a wide range of organic brain dysfunction. In their mild forms, these symptoms are present to varying degrees in many elderly persons. Not infrequently, as the symptoms persist or worsen, medical assistance is sought; in our “medicated” society both elderly patient and doctor may agree that drugs will be beneficial.


Change Score Psychotropic Drug Antidepressant Effect American Geriatrics Society Target Symptom 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hander, M.: The use of selected phenothiazines in elderly patients: A review. J. Mount Sinai Hosp. N.Y. 32: 622–633, 1965.Google Scholar
  2. 2.
    Wechsler, D.: A standardized memory scale for clinical use. J. Psychol. 19: 87–95, 1945.CrossRefGoogle Scholar
  3. 3.
    Scheier, I. H., Cattell, R.S., and Sullivan, W.P.: Predicting anxiety from symptoms of anxiety. Psychiat. Quart. (suppl) 35: 114–126, 1961.Google Scholar
  4. 4.
    McNair, D.M., and Lorr, M.: An analysis of mood in neurotics. J. Abnorm. Psycho. 69: 620–627, 1964.CrossRefGoogle Scholar
  5. 5.
    Kirk, R.E.: Experimental Design: Procedures for the behavioral sciences. Belmont, Calif., Brooks Cole, 1969, p. 79.Google Scholar
  6. 6.
    Shader, R.I., and DiMascio, A.: Drug studies in normals: Sex differences. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Las Vegas, Nev., January 21, 1972.Google Scholar
  7. 7.
    Prange, A.J., Wilson, I.C., Know, A.E., McClane, T.K., Breese, G.R., Martin, B.R., Alltop, L.B., and Lipton, M.A.: Thyroid-imipramine interaction: Clinical results and basic mechanism in Brain Chemistry and Mental Disease. Ho, Bent T., and Mclsaac, William M. (ed), New York, Plenum Press, 1971, p. 197.Google Scholar
  8. 8.
    Salzman, C., Shader, R.I., Kochansky, G.E. and Cronin, D.M.: Rating scales for research with geriatric patients. I. Behavior Ratings. J. American Geriatrics Society 20: 209–214, 1972.Google Scholar
  9. 9.
    Salzman, C., Kochansky, G.E., Shader, R.I., and Cronin, D.M.: Rating scales for psychotropic drug research with geriatric patients. II Mood ratings. J. American Geriatrics Society 20: 215–221, 1972.Google Scholar
  10. 10.
    Salzman, C., Kochansky, G.E., and Shader, R.I.: Rating scales for geriatric psychopharmacology: A review. Psychopharmacology Bulletin 8: 3–50, 1972.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1973

Authors and Affiliations

  • Carl Salzman
  • Richard I. Shader

There are no affiliations available

Personalised recommendations